Weekly production has doubled since May
First clearance for advancement in CT in nearly a decade
Researchers discover mutational signature of dose damage
Post-processing of DDR data through Konica Minolta’s Intelligent Workstation allowed for detailed measurements
Raising the profile of radiation oncology
Building evidence for treating pediatric and prostate cancers.
Radioisotopes' half-lives make them perishable
Fear deploying a treatment plan made by an inadequate algorithm
Treating up to 16 patients daily with Pluvicto and other radiopharmaceuticals
Expected to open in 2019 — along with Apollo Proton Therapy Centre
$300 million in cuts could also lead to layoffs.
Production limitations have made Ac-225 supplies challenging to access
Costs expected to be on par with more conventional radiation therapy
Reduces risk of heart attack
Mirion Medical Brands Present Solution Together at 2023 RSNA Annual Meeting
